Key result
Abstract omits results evaluating CHADS2, CHA2DS2-VASc, and R2-CHADS2 scores for major cardiovascular events in post-PCI NSTEMI patients.
Why the study?
NSTEMI carries a poor prognosis, making accurate prognostication of significant clinical importance.
Do CHADS2, CHA2DS2-VASc, and R2-CHADS2 scores predict short- and long-term major adverse cardiac events in patients with NSTEMI following PCI?
Cohort
Yes
Do CHADS2, CHA2DS2-VASc, and R2-CHADS2 scores predict short- and long-term major adverse cardiac events in patients with NSTEMI following PCI?
Answers are grounded in this paper and cite their sources.
No abstract-reported results on CHADS2/CHA2DS2-VASc/R2-CHADS2 for MACE in NSTEMI post-PCI; leaves open predictive value.
Background: Non-ST-elevation myocardial infarction (NSTEMI) carries a poor prognosis, and accurately prognostication has significant clinical importance. In this study, we analyzed the predictive value of the CHADS2, CHA2DS2-VASc, and R2-CHADS2scores for major adverse cardiac events (MACE) following percutaneous coronary intervention (PCI) in patients with NSTEMI using data from a prospective multicenter registry.
No takes yet. Share an insight, caveat, or question.
Horikoshi et al. (2023) conducted a cohort in Non-ST-segment elevation myocardial infarction (NSTEMI). CHADS2, CHA2DS2-VASc, and R2-CHADS2 scores was evaluated on Major adverse cardiac events (MACE).
Synapse has enriched 10 related papers. Consider them for comparative context: